i2E & Plains Ventures Surpasses $100M Milestone in Total Investments
Innovation 2 Enterprise
NOVEMBER 21, 2024
This milestone represents years of dedication to growing Oklahoma’s entrepreneurial ecosystem,” Plains Ventures President Justin Wilson said. “It Selexys Pharmaceuticals was acquired by Novartis for $665 million in October 2016. Novazyme Pharmaceuticals Inc. was acquired by Genzyme Corp for $137.5 million in 2001.
Let's personalize your content